Respiratory

Latest News

ILD | Image Credit: PH alex aviles - stock.adobe.com
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening

November 20th 2024

This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.

ISM001-055 is a novel drug developed through generative AI biotechnology | image credit: ipopba - stock.adobe.com
Novel, AI-Procured ISM001-055 Demonstrates Great Promise for Treatment of IPF

November 12th 2024

Nurses during COVID-19 experience burnout | Image Credit: Nina Lawrenson/peopleimages.com - stock.adobe.com
COVID-19 Leaves Lasting Impact on Nursing Practices and Job Satisfaction

October 31st 2024

IPF diagnosis | Image credit: Vitalii Vodolazskyi - stock.adobe.com
FIBRONEER-IPF Trial of Nerandomilast Meets Primary End Point

September 19th 2024

AI robot thinking | Image credit: phonlamaiphoto – stock.adobe.com
Are AI-Powered Robots the Future of Respiratory Health Care?

September 17th 2024

Continuing Medical Education
View All
November 21st 2024

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

More News

AJMC® in the Press, February 14, 2020
February 14th 2020

AJMC® in the Press, February 14, 2020

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
Knowledge About Effective Therapies for Interstitial Lung Disease Lacking, Review Says
February 14th 2020

Knowledge About Effective Therapies for Interstitial Lung Disease Lacking, Review Says

Rachel Lutz
Interstitial lung disease requires a multidisciplinary clinical approach, though little is known about effective therapeutic treatments.
Site Logo
February 12th 2020

Preventive Drug Lists as Tools for Managing Asthma Medication Costs

Melissa B. Gilkey, PhD Lauren A. Cripps, MA Rachel S. Gruver, MPH Deidre V. Washington, PhD Alison A. Galbraith, MD, MPH
Findings of this qualitative interview study suggest promise, but also challenges, with regard to using preventive drug lists to help families manage asthma medication costs.
Experts Warn of Child Flu Outbreak in Detention Centers
February 5th 2020

Experts Warn of Child Flu Outbreak in Detention Centers

Gianna Melillo
Infectious disease experts at the University of Maryland School of Medicine recently warned there is an urgent need for the administration of influenza vaccines among detainees at the southern border.
Lung Microbiome Found to Predict Outcomes in Critically Ill Patients
January 29th 2020

Lung Microbiome Found to Predict Outcomes in Critically Ill Patients

Matthew Gavidia
Key features of the lung microbiome (bacterial burden, enrichment with gut-associated bacteria) were found to predict outcomes in critically ill patients, representing a potential therapeutic target for the prevention and treatment of acute respiratory failure, according to study findings.
HHS Secretary Azar Issues Updates on Novel Coronavirus
January 29th 2020

HHS Secretary Azar Issues Updates on Novel Coronavirus

Gianna Melillo
In a press conference, HHS secretary Alex Azar provided updates on the US government’s response to the 2019 novel coronavirus. He was joined by the director of the CDC, Robert Redfield, MD; the director of CDC’s National Center for Immunization and Respiratory Diseases, Nancy Messonnier, MD; and the director of the National Institutes of Health’s National Institute of Allergy and Infectious Diseases, Anthony Fauci, MD.
Surgeon General Releases New Report on Smoking Cessation
January 24th 2020

Surgeon General Releases New Report on Smoking Cessation

Gianna Melillo
The US Surgeon General, Jerome M. Adams, MD, MPH, has released the first report since 1990 that focuses solely on smoking cessation in America. Smoking accounts for the deaths of half a million Americans each year and is the leading cause of preventable disease, disability, and death in the country.
What We're Reading: Healthcare Issues to Watch; e-Cig Flavor Ban; Google AI and Breast Cancer
January 2nd 2020

What We're Reading: Healthcare Issues to Watch; e-Cig Flavor Ban; Google AI and Breast Cancer

AJMC Staff
Five issues in healthcare were spotlighted as key developments to watch; FDA to ban all e-cig vape flavors except for menthol and tobacco; Google AI system shown to improve detection of breast cancer through mammograms.
Chemical Found in e-Cigarette Fluid Linked to Vaping-Related Respiratory Failure of Teen
November 13th 2019

Chemical Found in e-Cigarette Fluid Linked to Vaping-Related Respiratory Failure of Teen

Matthew Gavidia
The fluid in e-cigarettes were associated with the near fatal respiratory failure of a teenage boy who was found to have an exaggerated immune response to one of its chemicals while vaping, according to a report published this week by doctors.
Dr Lisa Lancaster on Evolving Treatments in Pulmonology
November 6th 2019

Dr Lisa Lancaster on Evolving Treatments in Pulmonology

New trials are looking at what could be the next therapy or one that layers on top of present therapies to treat lung diseases, said Lisa Lancaster, MD, assistant professor of medicine at Vanderbilt Health.
Clofazimine-Containing Regimen Shown to Safely, Effectively Treat Rapidly Growing Mycobacteria Infections
November 6th 2019

Clofazimine-Containing Regimen Shown to Safely, Effectively Treat Rapidly Growing Mycobacteria Infections

Matthew Gavidia
A clofazimine-containing regimen was found to be well tolerated and potentially effective in patients with rapidly growing mycobacteria infection, especially nonpulmonary and non–Mycobacterium abscessus complex infections, according to retrospective cohort study findings.
Outcomes-Based Contract Between Highmark, AstraZeneca Reveals Positive Results for Patients With Asthma and COPD
November 2nd 2019

Outcomes-Based Contract Between Highmark, AstraZeneca Reveals Positive Results for Patients With Asthma and COPD

Matthew Gavidia
Highmark announced this week that its outcomes-based contract with AstraZeneca for the respiratory combination medication of budesonide/formoterol (Symbicort) revealed positive results in improving outcomes for those with asthma and chronic obstructive pulmonary disease (COPD).
Top 5 AJMC® Articles of October 2019
November 1st 2019

Top 5 AJMC® Articles of October 2019

Here are the top 5 articles for the month of October.
Researchers Explore Costs of Switching to Environmentally Friendly Inhalers for Asthma
October 31st 2019

Researchers Explore Costs of Switching to Environmentally Friendly Inhalers for Asthma

Christina Mattina
Reducing the use of metered-dose inhalers for asthma could shrink the carbon footprint while achieving cost savings if less expensive brands of dry powder inhalers are used, according to new research findings.
This Week in Managed Care: October 25, 2019
October 25th 2019

This Week in Managed Care: October 25, 2019

This week, the top managed care news included the average Affordable Care Act premiums falling 4%; the FDA approving a triple combination treatment for cystic fibrosis; House Republicans releasing part 1 of their healthcare plan.
Dr Lisa Lancaster Discusses the Overlap of Sleep Apnea and Lung Diseases
October 22nd 2019

Dr Lisa Lancaster Discusses the Overlap of Sleep Apnea and Lung Diseases

Lisa Lancaster, MD, assistant professor of medicine at Vanderbilt Health, discusses how sleep apnea is a comorbidity for other lung diseases, such as chronic obstructive pulmonary disease (COPD) and interstitial lung disease.
FDA Approves Novel Triple Combination Therapy for Cystic Fibrosis
October 22nd 2019

FDA Approves Novel Triple Combination Therapy for Cystic Fibrosis

Matthew Gavidia
The FDA approved the triple combination of elexacaftor, ivacaftor, and tezacaftor, to be sold under the name Trikafta, as a novel treatment among patients with the most common cystic fibrosis mutation.
Water Treatment Strategies Vary in Effectiveness Against Bacterial Species Causing Respiratory Infections
October 17th 2019

Water Treatment Strategies Vary in Effectiveness Against Bacterial Species Causing Respiratory Infections

Christina Mattina
Several species of bacteria that can transmit respiratory infections have varying levels of response to the disinfecting agents used in municipal water treatment systems, with no one water disinfection strategy achieving complete microbial control, according to new findings.
High Levels of Chronic Stress, High Blood Pressure Linked in African Americans
October 16th 2019

High Levels of Chronic Stress, High Blood Pressure Linked in African Americans

Matthew Gavidia
African Americans who report high levels of chronic stress were shown to be at a heightened risk of developing high blood pressure, or hypertension, with specific stressors such as discrimination and socioeconomic status serving as possible catalysts, according to study findings.
Exposure to e-Cigarette Smoke Associated With Lung Cancer in Mice
October 9th 2019

Exposure to e-Cigarette Smoke Associated With Lung Cancer in Mice

Matthew Gavidia
Long term e-cigarette impact on humans remains unknown, although studies on mice suggest potentially harmful consequences for users.
Research Identifies Asthma Endotypes Suggesting Different Treatment Strategies
October 9th 2019

Research Identifies Asthma Endotypes Suggesting Different Treatment Strategies

Christina Mattina
An in-press study detailed the characteristics of 4 asthma endotypes and their association with asthma-related healthcare outcomes and responsiveness to treatment.
Three-in-One Inhaler Found to Improve Lung Function, Reduce Asthma Attacks in 2 Phase 3 Trials
October 3rd 2019

Three-in-One Inhaler Found to Improve Lung Function, Reduce Asthma Attacks in 2 Phase 3 Trials

Matthew Gavidia
Research presented at the European Respiratory Society Conference 2019 details the novel use of a single inhaler combining 3 therapies, as opposed to 2, in 2 clinical studies on patients with severe asthma.
Phase 2 Pirfenidone Trial Indicates Potential Effectiveness in Treating Patients With Unclassifiable ILD
October 1st 2019

Phase 2 Pirfenidone Trial Indicates Potential Effectiveness in Treating Patients With Unclassifiable ILD

Matthew Gavidia
Pirfenidone was shown to potentially benefit patients with uILD in a phase 2 trial, according to research presented at the European Respiratory Society Congress 2019 in Madrid, Spain.
Asthma Education and Severity Control on the Decline, With Primary Care Providers Undertaking Nearly Two-Thirds of Asthma-Related Visits
September 27th 2019

Asthma Education and Severity Control on the Decline, With Primary Care Providers Undertaking Nearly Two-Thirds of Asthma-Related Visits

Matthew Gavidia
Adherence to documenting asthma severity or control and providing ample education to patients was low among physicians from 2012-2015, with primary care providers monitoring nearly two-thirds of asthma-related visits, according to a federal report.
Flavored E-Cigarettes Linked With Worsening Severity of Asthma in Mice
September 21st 2019

Flavored E-Cigarettes Linked With Worsening Severity of Asthma in Mice

Matthew Gavidia
Flavored e-cigarettes without nicotine were shown to have differing asthma outcomes on mice based on the flavor, indicating that some flavors may worsen the severity of allergic airways disease, according to a new study.
Clinical, Radiologic Features Help to Distinguish Pulmonary Infections From Lung Cancers in Patients With HIV
September 18th 2019

Clinical, Radiologic Features Help to Distinguish Pulmonary Infections From Lung Cancers in Patients With HIV

Christina Mattina
Individuals with HIV are often susceptible to opportunistic pulmonary infections, but the lung lesions resulting from these infections can be mistaken for lung cancer, according to a new study that aimed to characterize features of OPIs versus tumors in patients with HIV.
Trump Administration Seeks to Rid Market of Flavored e-Cigarettes
September 11th 2019

Trump Administration Seeks to Rid Market of Flavored e-Cigarettes

Allison Inserro
The Trump administration said Wednesday that the FDA will “prioritize” enforcement of flavored e-cigarette regulations in an effort to get them removed from the market.
What We're Reading: FDA Investigating Juul; Sutter Health Handed Lawsuit; European Doctor Sues FDA
September 10th 2019

What We're Reading: FDA Investigating Juul; Sutter Health Handed Lawsuit; European Doctor Sues FDA

AJMC Staff
Juul is being investigated for making unauthorized safety claims, while the governor of New York proposes to ban flavored e-cigarettes; Sutter Health is being sued for its role in rising healthcare costs; a European doctor who uses telemedicine and internet prescribing to provide American women with mifepristone and misoprostol to induce abortion in the first trimester is suing the FDA.
School-Based Telehealth Programs Shown to Benefit Children With Asthma in Medically Underserved Communities
September 9th 2019

School-Based Telehealth Programs Shown to Benefit Children With Asthma in Medically Underserved Communities

Matthew Gavidia
School-based telemedicine was shown to potentially enhance healthcare benefits for children with chronic diseases, such as asthma, in rural and medically underserved communities, according to a study.
What We're Reading: Purdue Pharma Rejects Settlement; Vaping-Related Illnesses Rising; Harris Proposes Plan for Vets
September 9th 2019

What We're Reading: Purdue Pharma Rejects Settlement; Vaping-Related Illnesses Rising; Harris Proposes Plan for Vets

AJMC Staff
Oxycontin manufacturer rejects settlement for role in opioid epidemic and moves toward bankruptcy; new vaping-related respiratory illnesses reported; Senator Kamala Harris, D-California, a 2020 presidential candidate, proposes a new healthcare plan for veterans.
<1
...
101112131415161718
...
21>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo